Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page adds a 2015 NIH grant/contract note to the study details and updates the document revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:51:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a small maintenance update to the page. It does not indicate changes to the study results or core information.
    Difference
    0.1%
    Check dated 2026-08-08T19:16:23.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.6.3 to v3.6.4, reflecting a newer internal version in the footer.
    Difference
    0.1%
    Check dated 2026-07-25T12:55:29.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a platform update. This change does not modify the study details, eligibility criteria, outcomes, or other content presented on the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:11:10.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.0 to v3.6.2, signaling a minor platform update to the Study page. This change does not modify study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-06-27T02:03:40.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added recruitment status text No longer looking for participants and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) with a formatting update to the Intervention/Treatment label. Removed the old Intervention / Treatment heading and updated the revision to Revision: v3.6.0 replacing v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T16:07:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.